Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models
Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models have?
Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models has 46 citations in the OpenAlex counts ScholarIQ stores.
When was Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models published?
Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models has 2017 year in the ScholarIQ index.
What is the open-access status of Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models?
Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models has diamond oa status in the ScholarIQ index.
What is the DOI of Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models?
The DOI for Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models is on the source record.
What is the PMID of Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models?
The PMID for Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models is on the source record.
What is the OpenAlex record for Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models?
The OpenAlex for Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models is on the source record.